# NI-0401 in Patients With Acute Renal Allograft Rejection

> **NCT00805909** · PHASE1,PHASE2 · COMPLETED · sponsor: **Light Chain Bioscience - Novimmune SA** · enrollment: 12 (estimated)

## Conditions studied

- Acute Renal Transplant Rejection

## Interventions

- **DRUG:** NI-0401

## Key facts

- **NCT ID:** NCT00805909
- **Lead sponsor:** Light Chain Bioscience - Novimmune SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2009-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00805909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00805909, "NI-0401 in Patients With Acute Renal Allograft Rejection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00805909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*